- Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., Zeldis, J. and Barlogie, B. (1999) "Antitumor activity of thalidomide in refractory multiple myeloma", New Engl. J. Med. 341, 1565-1571.
- Kishi, Y., Oki, Y. and Machida, U. (2000) "Thalidomide in multiple myeloma", New Engl. J. Med. 342, 975-976.
- Juliusson, G., Celsing, F., Turesson, I., Lenhoff, S., Adriansson, M. and Malm, C. (2000) "Frequent good partial remission from and thalidomide including best ever responses with advanced refractory and relapsed myeloma", Br. J. Haematol. 109, 89-96.
- Kneller, A., Raanani, P., Hardan, I., Avigdor, A., Levi, I., Berkowicz, M. and Ben-Bassat,I. (2000) "Therapy with thalidomide in refractory multiple myeloma patients--the revival of an old drug", Br. J. Haematol, 108, 391-393.
- Costello, R., Sainty, D., Bouabdallah, R., Fermand,J., Delmer, A., Divine, M., Marolleau, J., Gastaut, J., Olive,D., Rousselot, P. and Chaibi, P. (2001) "Primary plasma cell leukaemia: a report of 18 cases", Leuk. Res. 25(2), 103-107.
- Raje, N. and Anderson, K. (1999) "Thalidomide--a revival story", New Engl. J. Med. 341, 1606-1609.
- Hideshima, T., Chauhan, D., Shima, Y., Raje, N., Davies, F., Tai, Y., Treon, S., Lin, B., Sclossman, R., Richardson, P., Muller, G., Stirling, D. and Anderson, K.C. (2000) "Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy", Blood 96, 2943-2950.
- Parman, T., Wiley, M. J. and Well, P.G., (1999) "Free radical mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity", Nat. Med. 5, 582-585.
Leukemia & Lymphoma
Volume 43, 2002 - Issue 2